Tardive dyskinesia and antihistamines.

Area of Science:

• Pharmacology
• Neurology
• Clinical Medicine

Background:

• Antihistamines are widely used medications with a generally favorable safety profile.
• However, prolonged use can be associated with rare but significant adverse effects.
• Tardive dyskinesia is a potentially irreversible neurological disorder.

Observation:

• A patient developed tardive dyskinesia following extended antihistamine therapy.
• The clinical presentation of the movement disorder was characteristic of tardive dyskinesia.
• This case highlights a potential iatrogenic cause of tardive dyskinesia.

Findings:

• The prolonged administration of antihistamines was identified as the causative agent.
• The patient's tardive dyskinesia symptoms were successfully managed with haloperidol.
• Haloperidol demonstrated efficacy in treating antihistamine-induced tardive dyskinesia.

Implications:

• This finding suggests a need for increased awareness of tardive dyskinesia risk with antihistamines.
• Haloperidol may be a valuable therapeutic option for managing this specific type of tardive dyskinesia.
• Further research into the mechanisms and prevention of antihistamine-induced movement disorders is warranted.